Centre for Individualised Infection Medicine
The vision of the Centre for Individualised Infection Medicine (CIIM) is to individualise therapies for infectious diseases. CIIM is a joint venture of the Helmholtz Centre for Infection Research (HZI) and the Hannover Medical School (MHH) and was founded under the direction of Professor Michael P. Manns in December 2015. Researchers of the center will identify individual parameters that influence the progress of infection and will translate these findings into optimized and individualised care of patients with infectious diseases.
The research at the CIIM, which was founded in 2015, aims to consequently promote personalisation of health care in infection medicine.
In individualised medicine specific requirements of patients or patient groups are taken into account for an optimal risk-benefit assessment and subsequently improved therapy outcome. Systematic diagnostics allow the stratification of patients and thereby targeted prevention and tailored therapies.
The potential of personalised approaches in infection medicine is currently being underutilised. But individual parameters as age, pre-existing conditions or genetic and physiological prerequisites have a substantial effect on the course of disease.
The existing translational expertise in the Hannover-Braunschweig region, modern technology platforms and infrastructures including relevant patient cohorts offer optimal conditions to establish the CIIM as an internationally leading centre for individualised infection medicine.
Being initially a virtual centre, the CIIM will utilise infrastructures of the parental institutions to align, coordinate and further expand research activities in the field of personalised medicine. For a successful and sustainable implementation of the CIIM concept the research activities as well as CIIM groups will be brought together in a dedicated new building offering state-of-the-art infrastructure for life science and medical research in close proximity to Hannover Medical School and the TWINCORE institute. In addition, competence networks in medicine such as “Hep-Net” and “CAPNETZ” as well as research projects of the German Centre for Infection Research (DZIF) will be integrated into the centre. Thus, CIIM will form a unique focal point for translational medicine in infectious diseases.